Dimethyl sulfoxide as an inducer of differentiation in preosteoblast MC3T3‐E1 cells

William M.W. Cheung(University of Hong Kong), Awc Kung(University of Hong Kong)

FEBS Letters

December 6, 2005

10.1016/j.febslet.2005.11.062

Cited by 43

Related Papers

Sustained efficacy of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: Results of a 5-year, randomized, placebo-controlled study

|Bone|2010|9

Ocanacatib antifracture efficacy and saftey in postmenopausal women with osteoporosis: results from the phase III long-term adonacatib fracture trial (LOFT)

|Open Repository and Bibliography (University of Liège)|2015|3

Safety and Tolerability of Odanacatib Therapy in Postmenopausal Women with Osteoporosis: Results from the Phase III Long-Term Odanacatib Fracture Trial (LOFT)

|Data Archiving and Networked Services (DANS)|2014|3

Safety and tolerability of odanacatib therapy in postmenopausal women with osteoporosis: results from the phase III long-term odanacatib fracture trial

|Open Repository and Bibliography (University of Liège)|2014|2